Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (1-10 of 337) with videos related to

Pageof 34
Sort By:
Therapeutic Drug Monitoring|May 7, 2010
The role of therapeutic drug monitoring in pediatric HIV/AIDSDavid M Burger
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2014
[Health care consumers about over-the-counter drugs]David M Burger
Expert Opinion on Drug Metabolism & Toxicology|August 13, 2010
Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studiesDavid M Burger
European Journal of Medical Research|December 5, 2009
Drug-drug interactions with raltegravirDavid M Burger
Nederlands Tijdschrift Voor Geneeskunde|December 18, 2015
[What is the correct time to take medication?]Niels P Riksen, David M Burger
Gastroenterology|September 30, 2015
Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learnedDavid J Back, David M Burger
The Lancet. HIV|October 22, 2016
Improved labelling of antiretrovirals for paediatric useDavid M Burger, Annemarie Mc van Rossum
British Journal of Clinical Pharmacology|March 8, 2020
Cobicistat: A case of mislabelled drug-drug interaction risk?David M Burger, Alexandra Calmy, Catia Marzolini
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2010
Switching from efavirenz to nevirapineLuc Ben Stefan Gelinck, David M Burger
Current Opinion in HIV and AIDS|April 18, 2009
Use of therapeutic drug monitoring in HIV diseaseMatthijs van Luin, Paul Fm Kuks, David M Burger
Pageof 34

Showing results (1-10 of 337) with videos related to

Sort By:
Pageof 34
Therapeutic Drug Monitoring|May 7, 2010
The role of therapeutic drug monitoring in pediatric HIV/AIDSDavid M Burger
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2014
[Health care consumers about over-the-counter drugs]David M Burger
Expert Opinion on Drug Metabolism & Toxicology|August 13, 2010
Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studiesDavid M Burger
European Journal of Medical Research|December 5, 2009
Drug-drug interactions with raltegravirDavid M Burger
Nederlands Tijdschrift Voor Geneeskunde|December 18, 2015
[What is the correct time to take medication?]Niels P Riksen, David M Burger
Gastroenterology|September 30, 2015
Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learnedDavid J Back, David M Burger
The Lancet. HIV|October 22, 2016
Improved labelling of antiretrovirals for paediatric useDavid M Burger, Annemarie Mc van Rossum
British Journal of Clinical Pharmacology|March 8, 2020
Cobicistat: A case of mislabelled drug-drug interaction risk?David M Burger, Alexandra Calmy, Catia Marzolini
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2010
Switching from efavirenz to nevirapineLuc Ben Stefan Gelinck, David M Burger
Current Opinion in HIV and AIDS|April 18, 2009
Use of therapeutic drug monitoring in HIV diseaseMatthijs van Luin, Paul Fm Kuks, David M Burger
Pageof 34